Portable diagnostics company Cue raises $200M in IPO

Published on:

The diagnostics company currently has an authorized at-home Covid-19 test, and plans to expand into flu tests and other diagnostics. After pricing its stock at $16 per share, it climbed to $20 on Friday.

Read more    Source: medcitynews.com